Previous studies in patients with multiple myeloma (MM) or malignant lymphoma (ML) have reported that administration of pegfilgrastim alone or with plerixafor can mobilize, and increase the harvest of, CD34-positive cells15–17. This evidence concerns the gene CD34 and lymphoma.